Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07761351 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy

Study acronym: ENCOMPASS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 2 to 3
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 1 of 9 entries
  2. Recruitment opened
    • Study sites: 0 to 2
    • Start date changed from estimate of Aug 31, 2026 to Aug 28, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The ENCOMPASS study is a post-market, multicenter, randomized controlled trial comparing two established approaches for obtaining a biopsy of small pulmonary nodules (≤2 cm): CT-guided percutaneous lung nodule biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT (ssRAB with CBCT).
Trial Details
NCT Number NCT07761351
Lead Sponsor Intuitive Surgical
Conditions
(from sponsor)		 Lung Cancer (Diagnosis), Lung Nodule
Related terms Disease, Lung Neoplasms, Multiple Pulmonary Nodules
Enrollment 550 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov